
Opinion|Podcasts|November 30, 2023
Novel Investigational Approaches for the Treatment of Neovascular AMD
Listen
0:00 / 0:00
Dr Paul Hahn and Dr Michael Cohen explore upcoming treatments featuring innovative mechanisms of action and novel delivery systems for addressing neovascular AMD.
Advertisement
1:00 Retina specialists’ wish list for innovative therapies
6:40 Home OCT
8:43 Extending treatment intervals beyond four months
9:40 Therapies in the pipeline
15:00 Need for long-term retinal fluid suppression
16:00 Gene therapy
22:00 Helping patients facing end-stage vision loss
Advertisement
Latest CME
Advertisement
Advertisement
Trending on HCPLive
1
New Dyslipidemia Guidelines Reveal Significant Gap in LDL-C and LLT Treatment Goals
2
Agios Ends Tebapivat Development in Sickle Cell Disease After Phase 2
3
Counseling Patients On Exa-cel Gene Therapy Journey, With Haydar Frangoul, MD, MS
4
How Does the FDA Approval of Risankizumab Impact Pediatric Psoriasis and PsA? With Amy Paller, MD
5











































































